2026 Guidance

Business

CN Rail Posts Strong Q4 Gains but Warns of Flat Freight Volumes Ahead Amid Trade Uncertainty

Canadian National Railway reported improved revenue and operating income for the fourth quarter of 2025, citing productivity gains and recovery from prior-year port disruptions. However, the company issued a cautious outlook for 2026, forecasting 'flattish' freight volumes as U.S.-Canada trade tensions and a major regulatory review loom.

Jan 30, 2026

World

Germany Updates U.S. Travel Advisory Amid Immigration Crackdowns, Joining Wave of Nations Urging Caution

Germany has revised its official travel guidance for the United States, warning citizens of potential risks linked to immigration enforcement actions and civil unrest. The move aligns with a broader trend, as multiple allied nations have strengthened their advisories over the past year, reflecting growing international concern over U.S. domestic policies.

Jan 30, 2026

Business

Gentex Navigates Tariff Headwinds to Deliver Strong Q4, Eyes Growth in Driver Monitoring and Dimmable Tech

Gentex Corporation (GNTX) reported a 19% surge in Q4 2025 revenue to $644.4 million, bolstered by its VOXX acquisition. While core auto-dimming mirror sales held steady, the company achieved a significant five-point outperformance in its primary markets and hit its highest gross margin target since 2021, showcasing resilience against tariff pressures and setting a confident growth trajectory for 2026.

Jan 30, 2026

Business

CN Rail Navigates Headwinds to Post Solid Q4 Gains, Eyes Uncertain Trade Future

Canadian National Railway reported increased traffic, revenue, and operating income for the fourth quarter of 2025, citing productivity gains and a recovery from prior-year port disruptions. However, executives warn that ongoing U.S. trade policy uncertainty and tariffs continue to cloud the outlook for 2026.

Jan 30, 2026

Business

Regeneron Caps 2025 with Strong Quarter, Eyes Pipeline Expansion Amid EYLEA Transition

Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.

Jan 30, 2026

Business

Financial Institutions Inc. Caps Strong 2025 with Robust Earnings, Eyes Growth in Upstate NY Markets

Financial Institutions Inc. (FISI) reported solid Q4 and full-year 2025 results, with net income reaching $73.4 million. The community bank, leveraging its deep roots in Upstate New York, is positioning for further growth in 2026, buoyed by major local investments like Micron's semiconductor project.

Jan 30, 2026

Business

Air Products Posts Solid Q1 on Pricing Power and Cost Discipline, Charts Cautious Path Amid Macro Headwinds

Air Products and Chemicals reported a 10% rise in adjusted EPS for its fiscal first quarter, driven by strategic pricing and productivity gains. While management affirmed full-year guidance, they highlighted persistent challenges in the helium market and a cautious approach to major clean energy investments.

Jan 30, 2026

Business

Aon Posts Strong 2025, Eyes Steady Growth Amid Strategic Push

The global professional services firm reported sustained organic revenue growth and margin expansion for 2025, backed by its '3x3' strategic plan and technology investments. Leadership provided an upbeat outlook for 2026, targeting continued mid-single-digit growth and further profitability gains.

Jan 30, 2026

Business

Autoliv Drives to Record Highs on Asian Surge, Eyes Margin Growth Amid Market Shifts

The automotive safety giant posted historic sales and cash flow in 2025, powered by explosive growth with Chinese automakers and in India. While navigating a softer production forecast and tariff headwinds, management projects margin expansion for 2026.

Jan 30, 2026

Business

SoFi Posts Record Quarter, Eyes Aggressive Growth as Fintech Giant Hits Profitability Milestone

SoFi Technologies capped off a transformative 2025 with its first billion-dollar revenue quarter, fueled by explosive member growth and a strategic pivot toward fee-based services. As the digital finance leader sets ambitious targets for 2026, analysts are weighing its 'one-stop-shop' model against an evolving economic landscape.

Jan 30, 2026

Business

Selective Insurance Posts Strong 2025, Eyes Further Margin Gains Amid Commercial Auto Challenges

Selective Insurance Group reported robust profitability and investment returns for 2025, driven by disciplined underwriting actions. While celebrating an 18% book value growth, management detailed significant reserve strengthening in commercial auto and outlined a confident outlook for 2026, the year of its centennial.

Jan 30, 2026

Business

Financial Institutions Caps 'Strong' 2025 with Robust Earnings, Eyes Growth from Micron-Led Upstate NY Boom

Financial Institutions (FISI) reported solid Q4 and full-year 2025 results, beating guidance on key profitability metrics. Management highlighted disciplined loan growth, a strengthened capital position, and strategic shifts, while pointing to long-term opportunities from major industrial investments in its Upstate New York footprint.

Jan 30, 2026

Business

GCL Global Posts Soaring Revenue on Acquisition, But Swings to Loss Amid Integration Costs

GCL Global's fiscal first-half revenue nearly doubled after consolidating Ban Leong Technologies, yet the company reported a net loss as it absorbed acquisition costs. Management lowered full-year guidance, citing delays for two key game titles.

Jan 30, 2026

Business

Beyond the Headlines: Three European Stocks Poised to Defy Market Volatility in 2026

Amidst a backdrop of market uncertainty, investors are turning their attention to resilient companies with strong fundamentals. We spotlight three lesser-known European firms—from construction tech to cybersecurity and fashion retail—that are demonstrating robust growth and strategic positioning for the year ahead.

Jan 30, 2026

Business

Peloton's Path to Profitability: All Eyes on Cost Control as Earnings Loom

As Peloton Interactive prepares to report its Q2 fiscal 2026 results, investors are scrutinizing whether the fitness company's aggressive cost-cutting can finally fuel a sustainable turnaround, despite shares languishing 96% below their peak.

Jan 30, 2026

Business

Coveo Powers Record Quarter on AI Demand, Eyes Government Deals

Coveo Solutions Inc. (TSE:CVO) shattered its own records in fiscal Q3 2026, fueled by historic new bookings and surging demand for its enterprise-grade AI relevance platform. The company's focus on grounding generative AI in secure, governed data resonates as clients move from experimentation to operational deployment.

Jan 30, 2026

Business

Exco Technologies Navigates Market Shifts with Strong Automotive Performance, Offsetting Tooling Weakness

Exco Technologies Ltd. (TSE:XTC) kicked off its fiscal 2026 with a solid first quarter, posting higher profits despite a mixed demand environment. Robust growth in its Automotive Solutions segment successfully countered softer demand in its die-cast tooling business, showcasing the resilience of its diversified model amid ongoing trade policy and economic uncertainty.

Jan 30, 2026

Business

Waste Management Posts Record 2025 Results, Fuels Growth Through Efficiency and Sustainability Push

Waste Management capped off a strong 2025 with record cost performance and margin expansion, driven by operational discipline and its growing sustainability portfolio. The company forecasts continued growth for 2026, backed by robust cash flow and ambitious capital return plans.

Jan 30, 2026

Business

Thermo Fisher Scientific Caps 'Strong Year' with Robust Q4, Eyes Strategic Growth Amid Market Headwinds

Thermo Fisher Scientific reported a strong finish to 2025, with Q4 results exceeding expectations. While navigating currency volatility and tariffs, the life sciences giant highlighted growth in core biopharma sectors, strategic acquisitions like Clario, and a solid 2026 outlook.

Jan 30, 2026

Business

Stryker Caps Strong 2025 with Record Robotics Growth, Eyes Further Expansion Amid Tariff Headwinds

The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.

Jan 30, 2026